Status:
COMPLETED
Evaluation of the Safety and Effectiveness of the Oculeve Intranasal Lacrimal Neurostimulator in Patients With Dry Eye
Lead Sponsor:
Allergan
Collaborating Sponsors:
ORA, Inc.
Conditions:
Dry Eye Syndromes
Eligibility:
All Genders
22+ years
Phase:
NA
Brief Summary
The purpose of this study was to evaluate the safety and effectiveness of the Intranasal Tear Neurostimulator applied intranasally compared with the same device applied extranasally (control) in treat...
Eligibility Criteria
Inclusion
- Bilateral dry eyes
- Capable of providing written informed consent
Exclusion
- Chronic or recurring epistaxis (nosebleeds)
- Uncontrolled systemic disease
- Blood coagulation disorder
- Females who are pregnant, nursing or planning a pregnancy
Key Trial Info
Start Date :
November 17 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 8 2015
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT02313454
Start Date
November 17 2014
End Date
April 8 2015
Last Update
January 31 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Andover Eye Associates
Andover, Massachusetts, United States, 01810